-
Archives
- June 2018
- February 2018
- May 2017
- January 2017
- December 2016
- November 2016
- October 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- August 2015
- July 2015
- June 2015
- March 2015
- February 2015
- September 2014
- July 2014
- January 2014
- November 2013
- July 2013
- June 2013
- April 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- June 2012
- May 2012
- March 2012
- December 2011
- November 2011
- July 2011
- March 2011
-
Meta
Category Archives: Conference
Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – one week away
Joint Meeting of European Human Pharmacological Societies 17 May – 19 May, 2017, London You still have time to register for the EUFEMED 2017 conference – Exploratory Medicines Development: Innovation And Risk Management. The Faculty of Pharmaceutical Medicine has approved this event … Continue reading
Comments Off on Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – one week away
Abstract and Bursary deadlines 31-Jan-2017: Big Data & the Development of New Medicines
ITMAT in Edinburgh Big Data & the Development of New Medicines Friday 17 March 2017, Edinburgh, UK Registration and abstract submission are open for the Institute for Translational Medicine & Therapeutics (ITMAT) in Edinburgh Meeting, which will be held on ‘Big Data & … Continue reading
Comments Off on Abstract and Bursary deadlines 31-Jan-2017: Big Data & the Development of New Medicines
Big Data & the Development of New Medicines
ITMAT in Edinburgh Big Data & the Development of New Medicines Friday 17 March 2017, Edinburgh, UK Registration has begun for the Institute for Translational Medicine & Therapeutics (ITMAT) in Edinburgh Meeting, which will be held on the theme of ‘Big … Continue reading
Comments Off on Big Data & the Development of New Medicines
Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – registration open
Registration for the EUFEMED 2017 conference – Exploratory Medicines Development: Innovation And Risk Management has now opened. Members of AHPPI get substantial savings on the non-member prices ranging from £37 (early-bird workshop only) to £103.20 (early-bird workshop and conference) when including … Continue reading
Comments Off on Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – registration open
Exploratory medicines development – Innovation and risk management
First EUFEMED Conference Joint Meeting of European Human Pharmacological Societies Wednesday 17 May – Friday 19 May, 2017, London/UK Assessment and mitigation of risk are most challenging in exploratory drug development when a promising new compound is to be characterised … Continue reading
Comments Off on Exploratory medicines development – Innovation and risk management
EUFEMED Conference, May 2017, London
Save the date! The European Federation for Exploratory Medicines Development (EUFEMED) has scheduled it’s biennial conference for 17-19 May 2017 in London. The AHPPI will be organising the meeting and members will be entitled to a discounted rate. The programme is … Continue reading
Comments Off on EUFEMED Conference, May 2017, London
Survey Results for AHPPI’s Annual Meeting
Steffan Stringer, published 23-Dec-2015. Correspondence steffan.stringer@alwynconsulting.co.uk. ©2015 Steffan Stringer, Alwyn Consulting, www.alwynconsulting.co.uk This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original … Continue reading
Comments Off on Survey Results for AHPPI’s Annual Meeting
Update on the implementation of the new EU Clinical Trial Regulation’s transparency rules for early phase trials
Dr Ulrike Lorch, AHPPI Chair-elect Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link). The new EU Clinical Trials Regulation (EU CTR) is intended to stimulate innovation, research and development in Europe. … Continue reading
Comments Off on Update on the implementation of the new EU Clinical Trial Regulation’s transparency rules for early phase trials
Cardiac Safety – the regulatory perspective
Dr Krishna Prasad, MHRA Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link). Krishna reviewed the status quo pointing out that the regulations were a success in that no drugs having undergone E14 … Continue reading
Comments Off on Cardiac Safety – the regulatory perspective
Cardiac Safety – the industry perspective
Dr Boaz Mendzelevski, BioClinica Proceedings from AHPPI’s conference on Risk Management in Early Phase Clinical Trials, 29 Oct 2015 (link). This year marks the 10th anniversary of the introduction of the ICH E14 guideline which was introduced to provide … Continue reading
Comments Off on Cardiac Safety – the industry perspective